Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDLR | P01130 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4746331 | 0.85 | HDAC3 (0.54) | LDLRITGB3ITGA2BROCK2HDAC3 | |
| SCHEMBL29223347 | 0.79 | KLK7 (0.57) | ITGB3ITGA2BHDAC3HDAC1HDAC2 | |
| SCHEMBL6508976 | 0.78 | KMT2A (0.67) | ROCK2KMT2AALDH1A1NPSR1 | |
| SCHEMBL10198173 | 0.77 | ROCK2 (0.61) | LDLRROCK2KMT2AALDH1A1 | |
| SCHEMBL31227621 | 0.76 | KMT2A (0.60) | ROCK2HDAC3HDAC1HDAC2KMT2A | |
| SCHEMBL15197080 | 0.75 | MAPT (0.64) | HDAC3HDAC1HDAC2KMT2A | |
| SCHEMBL28051643 | 0.74 | — | — | |
| SCHEMBL29690252 | 0.74 | NPSR1 (0.50) | LDLRITGB3ITGA2BROCK2HDAC3 | |
| Hydrochloric Acid SCHEMBL28051567 | 0.73 | — | — | |
| SCHEMBL29850847 | 0.72 | EPHX2 (0.63) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008122667-A2 | UREYLENE DERIVATIVES | SCHOOL OF PHARMACY (GB) | 2008-10-16 | — | — | WO | disclosed |